Skip to content
Guardion Health Sciences
Guardion Health SciencesGuardion Health Sciences
  • About
  • Our Team
  • Portfolio
    • Lumega-Z
    • VectorVision
    • MapCat
    • GlaucoCetin
    • Transcranial Doppler Solutions
  • News and Events
  • Investors
  • Resources
    • Medical Foods
    • Research & Studies
    • Place an order for Lumega-Z
    • Place an order for GlaucoCetin
    • My Account
    • Blog
  • Contact
Search
  • About
  • Our Team
  • Portfolio
    • Lumega-Z
    • VectorVision
    • MapCat
    • GlaucoCetin
    • Transcranial Doppler Solutions
  • News and Events
  • Investors
  • Resources
    • Medical Foods
    • Research & Studies
    • Place an order for Lumega-Z
    • Place an order for GlaucoCetin
    • My Account
    • Blog
  • Contact

Distribution of Lutein and Zeaxanthin Stereoisomers in the Human Retina

Carotenoids, Lutein, Meso-Zeaxanthin, Zeaxanthin

Distribution of Lutein and Zeaxanthin Stereoisomers in the Human Retina By: RICHARD A. BONE, JOHN T. LANDRUM, LARRY M. FRIEDES, CHRISTINA M. GOMEZ, MARK D. KILBURN, EUGENIO MENENDEZ, IVONNE VIDAL, WEILI WANG

Read more

Stereochemistry of the Human Macular Carotenoids

Carotenoids, Lutein, Meso-Zeaxanthin, Zeaxanthin

Stereochemistry of the Human Macular Carotenoids By: Richard A. Bone, John T. Landrum, George W. Hime, Araceli Cains and Jenny Zamor

Read more
1
234567891011121314151617
…1819202122
Search
Categories
  • Age-Related Macular Degeneration (77)
  • Alpha-Tocopherol (1)
  • Angiogenesis (3)
  • Antioxidants (19)
  • AREDS (6)
  • Astaxanthin (5)
  • Autofluorescence Spectrometry (2)
  • Beta-Carotene (2)
  • Blog (13)
  • Bone (3)
  • CAREDS (2)
  • Carotenoids (44)
  • Cataract (18)
  • Chart (1)
  • Coenzyme Q10 (2)
  • Cognitive Health (7)
  • Conference 2013 (2)
  • Contrast Sensitivity (4)
  • Curcumin (1)
  • DHA (6)
  • Diabetes (1)
  • Diabetic Retinopathy (1)
  • Diacetate (2)
  • Diet (6)
  • FDA (16)
  • Flavonoids (1)
  • Folate (2)
  • FTC (1)
  • Genetics (4)
  • Glare Sensitivity (3)
  • Glaucocetin (11)
  • Glaucoma (6)
  • Guardion Science Advisory Board (1)
  • Heidelberg (1)
  • Heterochromatic flicker-photometry (6)
  • Homocysteine (1)
  • Illinois College of Optometry (1)
  • Industry (16)
  • Intraocular Pressure (1)
  • Landrum (2)
  • Lumega-Z (2)
  • Lumega-Z Competitors (2)
  • Lutein (72)
  • Luteolin (1)
  • Macular Pigment (MP) (30)
  • Macuscope (2)
  • Macushield (1)
  • MacuShield (1)
  • MAPCAT (5)
  • MAPCAT competitors (3)
  • Mark McCarty (6)
  • Marketing (3)
  • Medical Foods (2)
  • Melatonin (1)
  • Meso-Zeaxanthin (35)
  • MPOD (40)
  • NAD+ (1)
  • NADPH oxidase (1)
  • Neovascular AMD (3)
  • NHANES (1)
  • Nicotinamide (2)
  • NutraIngredients (14)
  • Ocular Health Formula (69)
  • Omega-3 (15)
  • Omega-6 (1)
  • Oxidative Stress (3)
  • photostress recovery (6)
  • phycocyanobilin (2)
  • Quantifeye (2)
  • Retinal Pigment Epithelium (4)
  • Selenium (2)
  • Serum Lipids (3)
  • Sheldon Hendler (2)
  • Supplyside West (11)
  • The Beaver Dam Eye Study (2)
  • The Blue Mountains Eye Study (1)
  • Videos (2)
  • Vision (3)
  • Visual Acuity (4)
  • Visual Performance (9)
  • Vitamin B12 (1)
  • Vitamin C (5)
  • Vitamin D (1)
  • Vitamin E (5)
  • ZeaVision (2)
  • Zeaxanthin (60)
  • Zinc (3)
Recent Posts
  • Fisetin and luteolin protect human retinal pigment epithelial cells from oxidative stress-induced cell death and regulate inflammation
  • Luteolin attenuates endotoxin-induced uveitis in Lewis rats
  • A Review of the Range of Effects of Niacinamide in Human Skin
  • Is There More to Glaucoma Treatment Than Lowering IOP?

Made In USA

Secure Checkout

  • GUARDION HEALTH SCIENCES, INC.
    15150 AVENUE OF SCIENCE, STE 200
    SAN DIEGO, CALIFORNIA 92128
  • TOLL FREE NUMBER
    1-800-873-5141 (US)
  • CUSTOMER SERVICE HOURS
    8:00 AM - 5:00 PM, Monday to Friday
    (PST - Pacific Standard Time)

Guardion Health Sciences is at the forefront of early detection, intervention and monitoring of numerous eye diseases that have epidemic or near-epidemic profiles and for which there is substantial market potential for the early diagnosis and treatment.

The Company’s current focus is on patients who are at risk for vision loss related to a  depleted macular pigment, particularly patients at risk for macular degeneration, patients with nerve damage in glaucoma and patients with circulatory dysfunction in the ocular vessels.

©2018 Guardion Health Sciences | Terms of Use | Privacy Policy
  • PRIVACY POLICY
  • TERMS & CONDITIONS
  • BLOG
  • SITEMAP
Bottom Menu
Go to Top